clarithromycin has been researched along with Heart Defects, Congenital in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bérard, A; Nordeng, H; Sheehy, O; Zhao, JP | 1 |
| Hernández-Díaz, S; Lin, KJ; Louik, C; Mitchell, AA; Yau, WP | 1 |
2 other study(ies) available for clarithromycin and Heart Defects, Congenital
| Article | Year |
|---|---|
Use of macrolides during pregnancy and the risk of birth defects: a population-based study.
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Cohort Studies; Erythromycin; Female; Heart Defects, Congenital; Humans; Infant, Newborn; Macrolides; Penicillins; Pregnancy; Pregnancy Trimester, First; Prenatal Exposure Delayed Effects; Quebec; Registries; Risk Factors | 2015 |
Safety of macrolides during pregnancy.
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Erythromycin; Female; Heart Defects, Congenital; Humans; Logistic Models; Macrolides; Pregnancy; Prenatal Exposure Delayed Effects; Pyloric Stenosis; Risk | 2013 |